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Synergistic catalysis in an artificial enzyme by simultaneous action of two 
abiological catalytic sites  
Zhi Zhou and Gerard Roelfes* 
 








Artificial enzymes, which are hybrids of proteins with abiological catalytic groups, have emerged 
as a powerful approach towards the creation of enzymes for new-to-nature reactions.  Typically, 
only a single abiological catalytic moiety is incorporated. Here, we introduce a design of an 
artificial enzyme that comprises two different abiological catalytic moieties and show that these 
can act synergistically to achieve high activity and enantioselectivity, up to >99% e.e., in the 
catalyzed Michael addition reaction. The design is based on the transcriptional regulator LmrR as 
the protein scaffold and combines a genetically encoded unnatural p-aminophenylalanine residue, 
which activates an enal through iminium ion formation, and a supramolecularly bound Lewis acidic 
Cu(II) complex, which activates the Michael donor by enolization and delivers it to one preferred 
prochiral face of the activated enal. This study demonstrates that synergistic combination of 
abiological catalytic groups is a powerful approach to achieving catalysis normally outside the 





The drive for a more sustainable approach to chemical synthesis has spurred the development of 
artificial enzymes for reactions that have no equivalent in nature.1,2 A key challenge in the design 
of such artificial enzymes is the creation of the active site.  An important approach involves the 
introduction of abiological catalytically active moieties, which could be transition metal complexes 
or organocatalytic groups,3–7 in stable protein scaffolds that give rise to basal level of activities, 
that can then be improved by fine-tuning the protein environment by mutagenesis.8,9 Current efforts 
towards the creation of artificial enzymes have focused exclusively on introducing a single 
abiological catalytic moiety.3 However, the enviable rate accelerations and selectivities achieved 
by natural enzymes in part relate to nature’s ability to combine multiple catalytic strategies in a 
synergistic fashion.10 Here, we now report an artificial enzyme containing two abiological catalytic 
moieties that engage in synergistic catalysis to achieve highly enantioselective Michael addition 
reactions. 
Synergistic catalysis is a concept in which two substrates of a bimolecular reaction, e.g. an 
electrophile and nucleophile, are activated simultaneously by separate catalytic moieties. This 
causes a dramatic lowering of the HOMO−LUMO gap, which translates into a significant 
acceleration of the reaction.11,12 It is increasingly applied in homogeneous catalysis, for example in 
the combination of transition-metal catalysis and amino organocatalysis.13–16 Yet, the catalytic 
efficiency of such approaches is inherently limited by the entropic cost of bringing two activated 
substrates together in a productive orientation.17 In contrast, placement and orientation of reactive 
groups in the defined space of an active site is a hallmark of enzymes. Hence, we envisioned that 
placing two abiological groups at judicious positions in a stable protein scaffold would result in a 
highly efficient and selective artificial enzyme. 
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Our design of the artificial enzymes is based on the Lactococal multidrug resistance 
Regulator (LmrR), a small homodimeric transcription regulator from L. lactis that has been 
demonstrated to be a remarkably versatile scaffold for the design and creation of artificial (metallo-
)enzymes (Figure 1-a).18–20 The choice for this protein relates to its attractive structure: it contains 
an unusually large hydrophobic pocket at the dimeric interface with at its center two tryptophan 
moieties W96 and W96’, one from each monomer, that are key contributors to its binding of guest 
molecules via π stacking interactions. We have previously taken advantage of this promiscuous 
guest binding for introduction of abiological metal cofactors such as Cu(1,10-
phenanthroline)(NO3)2 (Cu(II)-phen) by supramolecular interactions. This resulted in an artificial 
metalloenzyme for enantioselective conjugate addition of indoles to enones, in which the Cu(II)-
phen cofactor acts as a Lewis acid for the activation of the enone (Figure 1-b).21  
An alternative approach involves introduction of catalytic groups by using expanded genetic 
code methods, i.e. stop codon suppression.22–24 Recently we have reported on the application of 
this methodology for the creation of a designer enzyme featuring a unnatural catalytic p-
aminophenylalanine (pAF) residue,4,5 Here, the aniline side chain of pAF was used as nucleophilic 
catalyst for formation of hydrazones from aldehydes (Figure 1-c). The reaction involves the 
transient formation of an iminium ion intermediate, which is a common activation strategy in many 
organocatalytic reactions.25 The central tryptophan residues in this case are proposed to contribute 
to substrate binding. We envisioned that both these design approaches can be combined into a 
single protein, to create an artificial enzyme with two abiological catalytic sites capable of acting 
simultaneously.  
Here we report a design of such an artificial enzyme comprising two different abiological 
catalytic moieties and show that these can act synergistically for the catalysis of enantioselective 
Michael addition reactions. In our design an α,β-unsaturated aldehyde is activated through iminium 
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ion formation with the aniline residue, while the enolate is formed by activation of a ketone 
precursor by the Lewis acidic Cu(II)-phenanthroline complex to give the Michael addition product 
(Figure 1-d). The nucleophile bound copper complex will be bound between the tryptophan 
moieties, resulting in delivery of the enolate to one preferred prochiral face of the activated enone. 
These artificial enzymes give rise to high activity and enantioselectivity, up to >99% e.e, in the 






Figure 1. Artificial enzyme designs based on LmrR. (a) The promiscuous binding pocket of LmrR with one pair of 
central tryptophan residues. (b) Previous work based on LmrR: Enantioselective Friedel-Crafts reaction catalyzed by 
Artificial metalloenzymes which is recruiting Cu(II)-phenanthroline to the LmrR pore by supramolecular assembly. 
(c) Designer enzyme with an unnatural catalytic aniline residue for hydrazone formation. (d) This work: Asymmetric 
Michael addition reaction catalyzed by synergistic combination of two catalytic sites: a pAF residue for the activation 






Creation of the artificial enzyme. The LmrR variant used in this study, referred to as 
LmrR_V15pAF, contains a non-canonical pAF residue at position 15 inside the hydrophobic pore.4 
The pAF residue can be introduced directly using the dedicated orthogonal translation system,26 
but in our experience it is most practical to use the system for incorporation of p-
azidophenylalanine (pAzF), followed by Staudinger reduction with tris(2-carboxyethyl)phosphine 
(TCEP), which was added to the protein solution after STREP-tag affinity purification, but before 
the final dialysis step. Hence, no additional handling steps were required compared to direct 
incorporation of pAF. 
The Lewis acidic site was then introduced through supramolecular self-assembly, by 
combining LmrR_V15pAF with Cu(II)-phen in a buffered solution (20 mM MOPS, 150 mM NaCl, 
pH 7.0). The binding affinity of Cu(II)-phen to LmrR_V15pAF was determined by titration through 
monitoring of the quenching of tryptophan fluorescence. A dissociation constant (Kd) of 0.53 μM 
was determined for binding of Cu(II)-phen to LmrR_V15pAF (Supplementary Figure 4), which is 
similar to the Kd reported for the binding of Cu(II)-phenanthroline to LmrR. This means the pAF 
residue does not negatively affect the binding of Cu(II)-complex to the two tryptophan residues 
(W96/W96’).  
 
Catalysis studies. The catalytic potential of the new artificial enzyme was evaluated in the 
enantioselective Michael addition reaction. While examples of promiscuous and designed enzyme 
employing iminium ion activation strategies for the catalysis of Michael additions have been 
reported, these generally involve the use of readily enolizable Michael donors for which no 
additional activation step is required.6,27–29 Here, we used the much less reactive ketone 1-(1-
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methyl-1H-imidazol-2-yl)-2-phenylethan-1-one (1a) as Michael donor. This ketone does not 
enolize spontaneously under the reaction conditions, but this can be achieved by binding to a Lewis 
acidic metal complex.30,31 Addition to acrolein (2a) then gives the Michael addition product 3a.32  
Less than 10% e.e. and a poor yield were obtained when using MacMillan-type chiral 
secondary amine catalysts for this reaction (Supplementary Figure 2). With other common amine 
organocatalyst(s) also a poor yield of product was obtained, while using these organocatalysts in 
combination with Cu(II)-phen, in absence of protein, did not result in product formation (Figures 
S1, S2).  These results suggest most amine catalysts are incompatible with the Cu(II)-phen 
complex. In contrast,  using LmrR_V15pAF/Cu(II)-phen,  prepared by self-assembly from 4 mol% 
of Cu(II)-phen (40 μM) with a slight excess (1.25 equiv) of LmrR_V15pAF (50 μM), the Michael 
addition product 3a was obtained in 36% yield with 86% e.e. (Table 1, entry 5). That the 
combination of the two catalytic sites is required for this reaction is evident from the fact that no 
product was formed when omitting one of the components from the catalyst, that is, using only 
LmrR_V15pAF or Cu(II)-phen or the combination of wild type LmrR, without pAF residue, and 
Cu(II)-phen (Table 1, entry 13). Using LmrR_V15pAF with Cu(NO3)2  as catalysts in the reaction 
resulted in 10% e.e. of 3a (Table 1, entry 4). This supports our hypothesis that the binding of copper 
complex to the two central tryptophan residues, which is mediated through the phenanthroline 
ligand,21 is important for the reaction to occur enantioselectively. Using copper complexes of 
ligands other than phenanthroline gave rise to lower enantioselectivities in the catalyzed reaction, 




Table 1. Results of Michael addition reactions catalyzed by LmrR_V15pAF/Cu(II)-phen 
 
Entry Catalysts Yield  (%)a e.e. (%)b 
1 LmrR_V15pAF / <1 ND 
2 / Cu(II)-phen <1 ND 
3 LmrR Cu(II)-phen <1 ND 
4 LmrR_V15pAF Cu(NO3)2 25 ± 8 10 ± 2 
5 LmrR_V15pAF Cu(II)-phen 36 ± 2 86 ± 1 
6c LmrR_V15pAF Cu(II)-phen 27 ± 3 81 ± 1 
Typical conditions: 0.8 equiv Cu(II)-phen (4 mol%; 40 μM) loading with respect to LmrR_V15pAF or LmrR (5 mol%; 50 μM), 
1 mM 1a, 10 mM 2a, in 20 mM MOPS buffer (pH 7.0), 150 mM NaCl, at 4 °C for 48 h, unless noted otherwise. Yield and e.e. 
values are the average of at least two independent experiments, both carried out in duplicate. All error values are given as standard 
deviation. aYields are determined by HPLC  analysis. be.e. values are determined by chiral HPLC. cReaction with 0.8 equiv 
Cu(II)-phen (2 mol%; 20 μM) loading with respect to LmrR_V15pAF (2.5 mol%; 25 μM). 
 
Encouraged by these results, we performed this reaction with crotonaldehyde instead of 
acrolein as Michael acceptor, which results in the simultaneous formation of two chiral centers. To 
our delight, the reaction with crotonaldehyde gave excellent enantioselectivities for both 
diastereomers with 98% and 86% e.e., respectively, when using the combination of  
LmrR_V15pAF with Cu(II)-phen (Table 2, entry 4). Using LmrR in combination with Cu(II)-phen 
and aniline, or another external chiral secondary amine catalyst (Table 2, entry 2 and 
Supplementary Figure 3,) gave no reaction, while using Cu(NO3)2, instead of Cu(II)-phen, in 
combination with LmrR_V15pAF resulted in dramatically lower e.e., d.r. and yield (Table 2, entry 
3). These results further support that physical separation of the aniline and Cu(II) complex, as well 
as precise positioning of these two with respect to each other, are important to achieve 
enantioselective catalysis. 
Further optimization of the reaction conditions gave rise to an increased yield and similar 
enantioselectivity (Supplementary Table 2) when using a small excess of Cu(II)-phen with respect 
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to LmrR_V15pAF at pH 6 (Table 2, entry 4). The kinetics of the reaction was measured as a 
function of crotonaldehyde concentration (1-25 mM), at a fixed ketone 1a concentration (1 mM). 
Saturation kinetics was observed and the initial rates were fitted to the Michaelis Menten equation, 
giving an apparent catalytic efficiency (kcat/KM(crotonaldehyde)) of 0.115 ± 0.017 M−1 s−1, an apparant 
kcat of  (2.58 ± 0.38) x 10-3 s-1and a KM(crotonaldehyde) of 22.5±5.84 mM (Supplementary Figure 6). 
The latter value is comparable to the KM measured for benzaldehyde derivatives in the recently 
reported hydrazone formation reaction catalyzed by LmrR_V15pAF, suggesting similar binding 



















N Buffer, 48 h, 4 C
3b
 
Entry Catalysts Yield (%)a d.r. b e.e. (%)b 
1 LmrR Cu(II)-phen <1 ND ND 
2c LmrR + aniline Cu(II)-phen <1 ND ND 
3 LmrR_V15pAF Cu(NO3)2 14 ± 3 1 : 1 57 ± 2/39 ± 1 
4 LmrR_V15pAF Cu(II)-phen 54 ± 2 3.5 : 1 98 ± 0/86 ± 2 
5c LmrR_V15pAF Cu(II)-phen 65 ± 1 4 : 1 98 ± 0/86 ± 1 
6d LmrR_V15pAF Cu(II)-phen 40 ± 2 4 : 1 98 ± 0/84 ± 1 
7e LmrR_V15pAF Cu(II)-phen 15 ± 1 4 : 1 98 ± 0/84 ± 0 
8f LmrR_V15pAF Cu(II)-phen 6 ± 1 4 : 1 99 ± 0/77 ± 1 
9c LmrR_V15pAF_W96A Cu(II)-phen 12 ± 2 1.2 : 1 82 ± 1/49 ± 2 
10c LmrR_V15pAF_M8R Cu(II)-phen 34 ± 3 4 : 1 98 ± 0/81 ± 1 
11c LmrR_V15pAF_M8D Cu(II)-phen 61 ± 1 3 : 1 96 ± 0/62 ± 2 
12c LmrR_V15pAF_M8W Cu(II)-phen 64 ± 3 7 : 1 99 ± 0/84 ± 2 
13c LmrR_V15pAF_M8I Cu(II)-phen 76 ± 2 6 : 1 >99 ± 0/88 ± 1 
14c LmrR_V15pAF_M8L Cu(II)-phen 82 ± 1 6 : 1 >99 ± 0/93 ± 1 
15d LmrR_V15pAF_M8L Cu(II)-phen 68 ± 2 6 : 1 >99 ± 0/93 ± 1 
16e LmrR_V15pAF_M8L Cu(II)-phen 36 ± 1 5.4 : 1 >99 ± 0/92 ± 0 
17f LmrR_V15pAF_M8L Cu(II)-phen 15 ± 2 5 : 1 >99 ± 0/90 ± 0 
Typical conditions: 0.8 equiv Cu(II)-phen (4 mol%; 40 μM) loading with respect to LmrR, LmrR_V15pAF or variants (5 mol%; 
50 μM), 1 mM 1a, 10 mM 2b, in 20 mM MOPS buffer (pH 7.0), 150 mM NaCl, at 4 °C for 48 h, unless noted otherwise. Yield 
and e.e. values are the average of at least two independent experiments, both carried out in duplicate. All error values are given 
as standard deviation. aYields are determined by HPLC. be.e. and d.r. values are determined by chiral HPLC. cLmrR (5 mol%; 50 
μM), aniline (5 mol%; 50 μM) and Cu(II)-phen (5 mol%; 50 μM).  dConditions: 1.2 equiv Cu(II)-phen (6 mol%; 60 μM) loading 
with respect to LmrR_V15pAF or variants (5 mol%; 50 μM), 1 mM 1a, 10 mM 2b, in 20 mM MES buffer (pH 6.0), 150 mM 
NaCl, at 4 °C for 48 h. d Reaction with 2.5 mol% protein and 3 mol% Cu(II)-phen loading. e Reaction with 1 mol% protein and 
1.2 mol% Cu(II)-phen loading. f Reaction with 0.5 mol% protein and 0.6 mol% Cu(II)-phen loading. Close-up of the hydrophobic 
pore in LmrR_pAF crystal structure (PDB: 6I8N). Catalytic aniline side chains (pink), Trp96 (yellow) and Met8 (red) are shown 
as sticks.   
 
Mutagenesis of LmrR. A limited mutagenesis study was performed. Removal of the Cu(II)-phen 
binding site by mutation of the central tryptophan residues to alanine, that is,  
LmrR_V15pAF_W96A with Cu(II)-phen resulted in a lower yield and e.e., as expected, confirming 
the importance of the precise positioning of the Cu(II)-bound enolate with respect to the activated 
enal (Table 2, entry 9). Mutagenesis of the methionine 8, which is directly adjacent to the central 
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tryptophans, has been found to be beneficial for catalysis in several instances.33 Several LmrR 
mutants, containing a variety of hydrophobic and charged side chains at position M8 were prepared 
and evaluated in catalysis (Table 2, entry 10-13). The variant LmrR_V15pAF_M8L displayed both 
improved stereoselectivity and reactivity compared to LmrR_V15pAF with >99/93% e.e., 6 : 1 d.r. 
and 82% yield (Table 2, entry 14). The catalyst loading could be lowered to 0.5 mol% without 
affecting the enantioselectivity (Table 2, entries 6-8, 16-17), confirming that the racemic 
background reaction is non-existent.  
 







LmrR_V15pAF + Cu(II)-phen LmrR_V15pAF_M8L + Cu(II)-phen 
Yield (%)a  d.r.b e.e. (%)b Yield (%)a d.r.b e.e. (%)b 
1 3a 42 ± 3 / 85 ± 2 35 ± 2 / 85 ± 1 
2 3b 65 ± 1 4 : 1 98 ± 0/86 ± 1 82 ± 1 6 : 1 >99 ± 0/93 ± 1 
3 3c 32 ± 3 4 : 1 98 ± 0/82 ± 1 48 ± 2 5 : 1 97 ± 0/85 ± 1 
4 3d 56 ± 6 2 : 1 61 ± 5/18 ± 2 52 ± 4 2 : 1 72 ± 3/12 ± 2 
5 3e 72 ± 3 8 : 1 99 ± 0/85 ± 1 90 ± 2 9 : 1 >99 ± 0/85 ± 1 
6 3f 53 ± 2 / 96 ± 1 55 ± 3 / 97 ± 0 
7 3g 80 ± 2 7 : 1 97 ± 0/67 ± 1 88 ± 1 8 : 1 98 ± 0/80 ± 1 
8 3h 46 ± 3 5 : 1 98 ± 0/72 ± 2 82 ± 2 6 : 1 >99 ± 0/81 ± 1 
Typical conditions: 1.2 equiv Cu(II)-phen (6 mol%; 60 μM) loading with respect to LmrR_V15pAF and LmrR_V15pAF_M8L 
(5 mol%; 50 μM), 1 mM 1, 10 mM 2, in 20 mM MES buffer (pH 6.0), 150 mM NaCl, at 4 °C for 48 h, unless noted otherwise. 
Yield and e.e. values are the average of at least two independent experiments, both carried out in duplicate. All error values are 




Investigation of substrate scope. The substrate scope of LmrR_V15pAF and 
LmrR_V15pAF_M8L with Cu(II)-phen was evaluated by variation of the α,β-unsaturated aldehyde 
and of the 2-acyl imidazole. The artificial enzyme tolerates a variety of α,β-unsaturated aldehydes. 
Replacing the methyl group at the β position of the unsaturated aldehyde with a propyl (2c) resulted 
in a similar e.e., whereas a phenyl at this position (2d) resulted in a lower e.e. (Table 3, entry 34). 
The reaction with the para-methoxy substitute 2-acyl imidazole and acrolein or crotonaldehyde 
both gave excellent e.e. and yield with both variants (Table 3, entry 56). The para-chloroe and 3-
thiophene substituted 2-acyl imidazole also shows excellent results in this reaction (Table 3, entries 
7-8). The mutant LmrR_V15pAF_M8L gave rise to either similar (with 3a and 3d) or higher yields 
and enantioselectivities than LmrR_V15pAF (in case of 3b, 3c, 3e, 3f, 3g and 3h).  
 
Mode of action of the artificial enzyme. The combined results of the binding studies and catalysis 
demonstrate unequivocally that the reaction takes place thanks to a synergistic combination of 
iminium ion activation of the unsaturated aldehyde by the pAF residue and the Cu(II)-
phenanthroline induced enolization of the ketone. The formation of an iminium ion intermediate 
from reaction of crotonaldehyde with the aniline moiety of LmrR_V15pAF is supported by the 
trapping of this intermediate with NaCNBH3 to give the corresponding reductive product, as shown 
by mass spectrometry.(Supplementary Figure 7). The binding of the Cu(II)-bound enolate between 
central tryptophan residues W96/W96′ is of key importance both for the activity and selectivity of 
the reaction. It brings the activated nucleophile and electrophile together, resulting in efficient C-
C bond formation. Moreover, it directs the attack of the nucleophile to one preferred prochiral face 
of the enone, resulting in excellent dia- and enantioselectivities of the product. Finally, the spatial 
separation of amine and Cu(II) catalytic sites ensures that the reaction can occur even though 
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aniline, and other amine catalysts, and Cu(II) complexes are incompatible when combined, without 
the protein.  
 
Conclusions.  
We have presented a design of an artificial enzyme, created by synergistic combination of an 
genetically encoded unnatural catalytic pAF residue with a catalytically active Cu(II) complex 
introduced by supramolecular binding in the hydrophobic cavity of the dimer interface of LmrR. 
The two key elements of the design are the promiscuity of the hydrophobic cavity of LmrR and the 
physical separation and judicious positioning of the two incorporated abiological catalytic sites, 
which circumvents problems related to incompatibility of the individual catalytic components, 
while allowing for efficient and selective approach of the nucleophile to the activated electrophile. 
The power of this approach was illustrated in the asymmetric Michael addition reaction in water, 
giving excellent stereoselectivity and reactivity. Finally, this study shows how the synergistic 
combination of two abiological catalytic groups can be employed to perform catalysis that is 
outside the realm of artificial enzymes containing a single abiological catalytic site. Our artificial 
enzyme design is highly flexible and allows for incorporation of other organocatalytic unnatural 
amino acids as well that it can binding other metal complexes.33 Thus, this study provides an 







Unless otherwise noted, chemicals were purchased from Sigma Aldrich and used without further 
purification. The unnatural amino acid pAzF was purchased as racemic mixture from Bachem 
(Switzerland). Plasmid pEVOL-pAzF was obtained from Addgene (pEVOL-pAzF was a gift from 
Prof. P. G. Schultz (The Scripps Research Institute), Addgene plasmid #31186).34 E. coli strains 
NEB5-alpha and BL21(DE3) (New England Biolabs, USA) were used for cloning and expression. 
Primers were synthesized by Eurofins MWG Operon (Germany) and restriction endonucleases 
purchased from New England Biolabs (USA). Plasmid Purification Kits were obtained from 
QIAGEN (Germany) and DNA sequencing carried out by GATC-Biotech (Germany). Pfu Turbo 
polymerase was purchased from Agilent (USA) and Strep-tactin columns (Strep-Tactin® 
Superflow® high capacity) from IBA-Lifesciences (Germany). Concentrations of DNA and protein 
solutions were determined based on the absorption at 260 nm or 280 nm on a Thermo Scientific 
Nanodrop 2000 UV-Vis spectrophotometer. UPLC/MS analysis was performed on a Waters 
Acquity Ultra Performance LC with Acquity TQD detector. Separation of proteins was achieved 
with an Acquity UPLC BEH C8 1.7 μm 2.1x150 mm column and a linear gradient of 90% to 50% 
water (0.1% FA) in ACN (0.1% FA) in 15 minutes. Theoretical molecular weights of proteins were 
calculated using the Expasy ProtParam tool (http://web.expasy.org./protparam/). Analytical size-
exclusion chromatography was carried out using a Superdex-75 10/300 GL size-exclusion column 
(GE Healtcare). Protein samples (100 μl) were injected and separated at a flow rate of 0.5 ml/min 
with 50 mM NaH2PO4, 150 mM NaCl buffer (pH 7.4). The column was calibrated using the 
standard Gel Filtration LMW Calibration Kit (GE Healtcare). 
Site-directed mutagenesis  
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The LmrR variant used as template for all mutants in this study is LmrR, which contains mutations 
at 2 lysines (K55D and K59Q) that abrogate the natural DNA-binding ability of the protein.4 Site-
directed mutagenesis was performed for the preparation of all LmrR variants used in this study 
(QuickChange, Agilent Technologies). Starting from the previously reported plasmid, 
pET17b_LmrR_LM,35 2 primers harboring appropriate mutations were used to generate UAG-
containing LmrR variants (a list of primers can be found in the Supplementary Information). The 
following PCR protocol was used: (1) initial denaturation at 95 ⁰C for 1 min, (2) 16 cycles of 
denaturation at 98 ⁰C for 30 s, annealing at 52-55 ⁰C for 30 s (depending on the Tm of the primers) 
and extension at 72 ⁰C for 4 min 30 s; (3) a final extension at 72 ⁰C for 10 min. The resulting PCR 
product was digested with DpnI for 2 hours at 37 ⁰C and transformed into chemically competent 
E. coli NEB5-alpha cells. A single colony was picked from LB plates containing ampicillin (100 
μg/mL) and used to inoculate 5 mL of LB medium containing the same concentration of ampicillin. 
Bacteria were grown overnight, plasmids isolated and variants harboring the correct mutations 
identified by sequencing. For protein expression, the plasmids pEVOL-pAzF and 
pET17b_LmrR_X were co-transformed into E. coli BL21(DE3) and a single colony was used to 
inoculate an overnight culture for protein expression and purification. 
Protein expression and purification 
LmrR_pAF variants were produced and purified purified as described previously.4 The identity of 
proteins and the successful reduction of pAzF were determined by mass spectrometry and the purity 
of the protein confirmed by SDS PAGE. Protein concentration was determined by correcting the 
calculated extinction coefficients for LmrR variants for the absorbance of pAF (ε280 = 1333 M-1 
cm-1). Analytical size-exclusion chromatography gave an elution volume (11.6 ± 0.2 ml) for all 
17 
 
LmrR mutants corresponded to a molecular weight of around 30 kDa, which is consistent with a 
homodimeric structure. 
General procedure for catalytic reactions and product characterization  
The catalytic solution was prepared by combining Cu(1,10-phenanthroline)(NO3)2 (Cu(II)-phen) 
(60 μM, 6 % catalyst loading) with LmrR_V15pAF_ or LmrR_V15pAF variants (50 μM, 5 % 
catalyst loading) in a final volume of 276 μL MES buffer (20 mM MES, 250 mM NaCl, pH 6.0) 
and incubating at 4 ⁰C for one hour. To this mixture, 12 μL of a fresh stock solution of substrate 1 
in DMF/MES buffer (50:50, 25 mM, final concentration in reaction mixture 1 mM) and 12 μL of 
a fresh stock solution of substrate 2 in DMF/MES buffer (50:50, 250 mM, final concentration in 
reaction mixture 10 mM) were added. The reaction was mixed for 2 days by continuous inversion 
at 4 ⁰C. Then the product was extracted with 2 x 1 mL of ethyl acetate, the organic layers were 
dried on Na2SO4, and the solvent was evaporated under reduced pressure. The product was 
redissolved in 120 μl of a heptane:propan-2-ol mixture (9:1) and the yield and enantiomeric excess 




We thank Reuben Leveson-Gower for assistance in preparation of the figures and Prof. Kathryn 
Splan for useful discussion. Support from the Netherlands Organisation for Scientific Research 
(NWO) (Vici grant 724.013.003) and the Ministry of Education, Culture and Science (Gravitation 






GR conceived and directed the project. ZZ performed the experimental work and analyzed the data. 
The authors discussed the results and wrote the manuscript together. Correspondence to GR. 
 
Data Availability 
All data that support the findings of this study are available within Figures and in the 




The authors declare no competing interests. 
 
References 
1. Hilvert, D. Design of Protein Catalysts. Annu. Rev. Biochem. 82, 447–470 (2013). 
2. Nanda, V. & Koder, R. L. Designing artificial enzymes by intuition and computation. Nat. 
Chem. 2, 15–24 (2010). 
3. Schwizer, F. et al. Artificial Metalloenzymes: Reaction Scope and Optimization Strategies. 
Chem. Rev. 118, 142–231 (2018). 
4. Drienovská, I., Mayer, C., Dulson, C. & Roelfes, G. A designer enzyme for hydrazone and 
oxime formation featuring an unnatural catalytic aniline residue. Nat. Chem. 10, 946–952 
(2018). 
5. Mayer, C., Dulson, C., Reddem, E., Thunnissen, A. M. W. H. & Roelfes, G. Directed 
Evolution of a Designer Enzyme Featuring an Unnatural Catalytic Amino Acid. Angew. 
Chem. Int. Ed. 58, 2083–2087 (2019). 
6. Nödling, A. R. et al. Reactivity and Selectivity of Iminium Organocatalysis Improved by a 
Protein Host. Angew. Chem. Int. Ed. 57, 12478–12482 (2018). 
7. Burke, A. J. et al. Design and evolution of an enzyme with a non-canonical 
organocatalytic mechanism. Nature 570, 219–223 (2019). 
8. Markel, U., Sauer, D. F., Schiffels, J., Okuda, J. & Schwaneberg, U. Towards the 
Evolution of Artificial Metalloenzymes-A Protein Engineer’s Perspective. Angew. Chem. 
Int. Ed. 58, 4454–4464 (2019). 
19 
 
9. Hyster, T. K. & Ward, T. R. Genetic Optimization of Metalloenzymes: Enhancing 
Enzymes for Non-Natural Reactions. Angew. Chem. Int. Ed. 55, 7344–7357 (2016). 
10. Sträter, N., Lipscomb, W. N., Klabunde, T. & Krebs, B. Two-Metal Ion Catalysis in 
Enzymatic Acyl- and Phosphoryl-Transfer Reactions. Angew. Chem. Int. Ed. 35, 2024–
2055 (1996). 
11. Allen, A. E. & MacMillan, D. W. C. Synergistic catalysis: A powerful synthetic strategy 
for new reaction development. Chem. Sci. 3, 633–658 (2012). 
12. Patil, N. T., Shinde, V. S. & Gajula, B. A one-pot catalysis: The strategic classification 
with some recent examples. Org. Biomol. Chem. 10, 211–224 (2012). 
13. Afewerki, S. & Córdova, A. Combinations of Aminocatalysts and Metal Catalysts: A 
Powerful Cooperative Approach in Selective Organic Synthesis. Chem. Rev. 116, 13512–
13570 (2016). 
14. Deng, Y., Kumar, S. & Wang, H. Synergistic-cooperative combination of enamine 
catalysis with transition metal catalysis. Chem. Commun. 50, 4272–4284 (2014). 
15. Krautwald, S., Schafroth, M. A., Sarlah, D. & Carreira, E. M. Stereodivergent α-Allylation 
of Linear Aldehydes with Dual Iridium and Amine Catalysis. J. Am. Chem. Soc. 136, 
3020–3023 (2014). 
16. Zhang, M. et al. Synergetic iridium and amine catalysis enables asymmetric [4+2] 
cycloadditions of vinyl aminoalcohols with carbonyls. Nat. Commun. 10, 2716 (2019). 
17. Du, Z. & Shao, Z. Combining transition metal catalysis and organocatalysis – an update. 
Chem. Soc. Rev. 42, 1337–1378 (2012). 
18. Agustiandari, H., Lubelski, J., Van Den Berg Van Saparoea, H. B., Kuipers, O. P. & 
Driessen, A. J. M. LmrR is a transcriptional repressor of expression of the multidrug ABC 
transporter LmrCD in Lactococcus lactis. J. Bacteriol. 190, 759–763 (2008). 
19. Madoori, P. K., Agustiandari, H., Driessen, A. J. M. & Thunnissen, A. M. W. H. Structure 
of the transcriptional regulator LmrR and its mechanism of multidrug recognition. EMBO 
J. 28, 156–166 (2009). 
20. Roelfes, G. LmrR: A Privileged Scaffold for Artificial Metalloenzymes. Acc. Chem. Res. 
52, 545–556 (2019). 
21. Bos, J., Browne, W. R., Driessen, A. J. M. & Roelfes, G. Supramolecular Assembly of 
Artificial Metalloenzymes Based on the Dimeric Protein LmrR as Promiscuous Scaffold. 
J. Am. Chem. Soc. 137, 9796–9799 (2015). 
22. Drienovská, I., Rioz-Martínez, A., Draksharapu, A. & Roelfes, G. Novel artificial 
metalloenzymes by in vivo incorporation of metal-binding unnatural amino acids. Chem. 
Sci. 6, 770–776 (2015). 
20 
 
23. Liu, C. C. & Schultz, P. G. Adding New Chemistries to the Genetic Code. Annu. Rev. 
Biochem. 79, 413–444 (2010). 
24. Dumas, A., Lercher, L., Spicer, C. D. & Davis, B. G. Designing logical codon 
reassignment - Expanding the chemistry in biology. Chem. Sci. 6, 50–69 (2015). 
25. Erkkilä, A., Majander, I. & Pihko, P. M. Iminium Catalysis. Chem. Rev. 107, 5416–5470 
(2007). 
26. Mehl, R. A. et al. Generation of a Bacterium with a 21 Amino Acid Genetic Code. J. Am. 
Chem. Soc. 125, 935–939 (2003). 
27. Guo, C., Saifuddin, M., Saravanan, T., Sharifi, M. & Poelarends, G. J. Biocatalytic 
Asymmetric Michael Additions of Nitromethane to α,β-Unsaturated Aldehydes via 
Enzyme-bound Iminium Ion Intermediates. ACS Catal. 9, 4369–4373 (2019). 
28. Garrabou, X., Verez, R. & Hilvert, D. Enantiocomplementary synthesis of γ-nitroketones 
using designed and evolved carboligases. J. Am. Chem. Soc. 139, 103–106 (2017). 
29. Garrabou, X., Macdonald, D. S., Wicky, B. I. M. & Hilvert, D. Stereodivergent Evolution 
of Artificial Enzymes for the Michael Reaction. Angew. Chem. Int. Ed. 57, 5288–5291 
(2018). 
30. Huo, H. et al. Asymmetric photoredox transition-metal catalysis activated by visible light. 
Nature 515, 100–103 (2014). 
31. Huang, X., Webster, R. D., Harms, K. & Meggers, E. Asymmetric Catalysis with Organic 
Azides and Diazo Compounds Initiated by Photoinduced Electron Transfer. J. Am. Chem. 
Soc. 138, 12636–12642 (2016). 
32. Zhang, D. H., Knelles, J. & Plietker, B. Iron-Catalyzed Michael Addition of Ketones to 
Polar Olefins. Adv. Synth. Catal. 358, 2469–2479 (2016). 
33. Villarino, L. et al. An Artificial Heme Enzyme for Cyclopropanation Reactions. Angew. 
Chem. Int. Ed. 57, 7785–7789 (2018). 
34. Chin, J. W. et al. Addition of p -Azido- l -phenylalanine to the Genetic Code of 
Escherichia coli. J. Am. Chem. Soc. 124, 9026–9027 (2002). 
35. Bos, J., García-Herraiz, A. & Roelfes G. An enantioselective artificial metallo-hydratase. 
Chem. Sci. 4, 3578–3582 (2013). 
 
